These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 7852525)

  • 21. Follicle-stimulating hormone-secreting pituitary adenoma manifesting as recurrent ovarian cysts in a young woman--latent risk of unidentified ovarian hyperstimulation: a case report.
    Kawaguchi T; Ogawa Y; Ito K; Watanabe M; Tominaga T
    BMC Res Notes; 2013 Oct; 6():408. PubMed ID: 24119690
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recognition of gonadotroph adenomas in women.
    Daneshdoost L; Gennarelli TA; Bashey HM; Savino PJ; Sergott RC; Bosley TM; Snyder PJ
    N Engl J Med; 1991 Feb; 324(9):589-94. PubMed ID: 1899470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ovarian hyperstimulation syndrome due to follicle-stimulating hormone-secreting pituitary adenomas.
    Caretto A; Lanzi R; Piani C; Molgora M; Mortini P; Losa M
    Pituitary; 2017 Oct; 20(5):553-560. PubMed ID: 28676954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gonadotroph cell pituitary adenomas.
    Snyder PJ
    Endocrinol Metab Clin North Am; 1987 Sep; 16(3):755-64. PubMed ID: 3319601
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spontaneous ovarian hyperstimulation syndrome caused by a follicle-stimulating hormone-secreting pituitary macroadenoma in an early pubertal girl.
    Gryngarten MG; Braslavsky D; Ballerini MG; Ledesma J; Ropelato MG; Escobar ME
    Horm Res Paediatr; 2010; 73(4):293-8. PubMed ID: 20215777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spontaneous ovarian hyperstimulation caused by a follicle-stimulating hormone-secreting pituitary adenoma.
    Roberts JE; Spandorfer S; Fasouliotis SJ; Lin K; Rosenwaks Z
    Fertil Steril; 2005 Jan; 83(1):208-10. PubMed ID: 15652911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A spontaneous and severe hyperstimulation of the ovaries revealing a gonadotroph adenoma.
    Christin-Maitre S; Rongières-Bertrand C; Kottler ML; Lahlou N; Frydman R; Touraine P; Bouchard P
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3450-3. PubMed ID: 9768644
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure-function correlations of human pituitary gonadotroph adenomas in vitro.
    Asa SL; Gerrie BM; Kovacs K; Horvath E; Singer W; Killinger DW; Smyth HS
    Lab Invest; 1988 Apr; 58(4):403-10. PubMed ID: 2451766
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gonadotroph Pituitary Adenoma Causing Treatable Infertility and Ovarian Hyperstimulation Syndrome in Female Patients: Neurosurgical, Endocrinologic, Gynecologic, and Reproductive Outcomes.
    Hasegawa H; Nesvick CL; Erickson D; Cohen SC; Yolcu YU; Khan Z; Raghunathan A; Nippoldt TB; Atkinson JL; Van Gompel JJ
    World Neurosurg; 2021 Jun; 150():e162-e175. PubMed ID: 33684575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exacerbation of ovarian hyperstimulation by leuprolide reveals a gonadotroph adenoma.
    Castelbaum AJ; Bigdeli H; Post KD; Freedman MF; Snyder PJ
    Fertil Steril; 2002 Dec; 78(6):1311-3. PubMed ID: 12477530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An immunohistochemical and ultrastructural study of a follicle-stimulating hormone-secreting gonadotroph adenoma occurring in a 10-year-old girl.
    Tashiro H; Katabuchi H; Ohtake H; Yoshioka A; Matsumura S; Suenaga Y; Nagamura Y; Matsuura K; Okamura H
    Med Electron Microsc; 2000; 33(1):25-31. PubMed ID: 11810454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Responses to gonadotropin releasing hormone agonist and antagonist administration in patients with gonadotroph cell adenomas.
    Chanson P; Lahlou N; Warnet A; Roger M; Sassolas G; Lubetzi J; Schaison G; Bouchard P
    J Endocrinol Invest; 1994 Feb; 17(2):91-8. PubMed ID: 8006338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spontaneous ovarian hyperstimulation syndrome and pituitary adenoma: incidental pregnancy triggers a catastrophic event.
    Baba T; Endo T; Kitajima Y; Kamiya H; Moriwaka O; Saito T
    Fertil Steril; 2009 Jul; 92(1):390.e1-3. PubMed ID: 19356755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Follicle-stimulating hormone-secreting pituitary adenomas: correlation of reduction of adenoma size with reduction of hormonal hypersecretion after transsphenoidal surgery.
    Harris RI; Schatz NJ; Gennarelli T; Savino PJ; Cobbs WH; Snyder PJ
    J Clin Endocrinol Metab; 1983 Jun; 56(6):1288-93. PubMed ID: 6404924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gonadotropin-releasing hormone agonists are unsuccessful in reducing tumoral gonadotropin secretion in two patients with gonadotropin-secreting pituitary adenomas.
    Sassolas G; Lejeune H; Trouillas J; Forest MG; Claustrat B; Lahlou N; Loras B
    J Clin Endocrinol Metab; 1988 Jul; 67(1):180-5. PubMed ID: 2967850
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functioning gonadotroph adenoma with severe ovarian hyperstimulation syndrome: A new emergency in pituitary adenoma surgery? Surgical considerations and literature review.
    Graillon T; Castinetti F; Chabert-Orsini V; Morange I; Cuny T; Albarel F; Brue T; Dufour H
    Ann Endocrinol (Paris); 2019 Apr; 80(2):122-127. PubMed ID: 30825998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abnormal response of luteinizing hormone beta subunit to thyrotrophin-releasing hormone in patients with non-functioning pituitary adenoma.
    Gil-del-Alamo P; Pettersson KS; Saccomanno K; Spada A; Faglia G; Beck-Peccoz P
    Clin Endocrinol (Oxf); 1994 Nov; 41(5):661-6. PubMed ID: 7828356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Usefulness of thyrotropin-releasing hormone test, SMS 201-995, and bromocriptine in the diagnosis and treatment of gonadotropin-secreting pituitary adenomas.
    Blanco C; Lucas T; Alcañiz J; Davila N; Serrano P; Barcelò B; Estrada J
    J Endocrinol Invest; 1994 Feb; 17(2):99-104. PubMed ID: 8006339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A clinically functioning gonadotroph adenoma presenting with abdominal pain, ovarian hyperstimulation and fibromatosis.
    Broughton C; Mears J; Williams A; Lonnen K
    Endocrinol Diabetes Metab Case Rep; 2018; 2018():. PubMed ID: 30532999
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduction of follicle-stimulating hormone (FSH) secretion in FSH-producing pituitary adenoma by bromocriptine.
    Berezin M; Olchovsky D; Pines A; Tadmor R; Lunenfeld B
    J Clin Endocrinol Metab; 1984 Dec; 59(6):1220-3. PubMed ID: 6436289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.